Mortality News and Research

RSS

Tissue Solutions and CBSB join forces to increase COVID-19 sample availability

The UK’s leading supplier of human tissue samples is joining forces with a Cambridge Biobank to provide COVID-19 samples for scientists.

15 May 2020

Experts urge health systems to fast-track implementation of Patient Blood Management

In a new article published in print Anesthesia & Analgesia, a group of 43 leading experts have called for health systems to fast-track the implementation of Patient Blood Management.

15 May 2020

SARS-CoV-2 will infect 250 million people in Africa

A study conducted by the World Health Organization (WHO) has predicted that the coronavirus will infect almost one-quarter of a billion people in Africa during the first year of the pandemic. Unless immediate measures are taken to control the spread of the virus, as many as 190,000 of them are likely to die, the researchers warn.

14 May 2020

New insights into SARS-CoV-2 viral diversity

The first comprehensive, large-scale analysis available on the preprint server bioRxiv attempted to identify specific genomic signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains within and across individual hosts – revealing recombination events, specific geographic profiles, as well as multi-strain and/or superinfections characteristic for the coronavirus disease (COVID-19) pandemic.

14 May 2020

ACTG initiates clinical trial to evaluate treatment for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).

14 May 2020

Anti-inflammatory drug may improve respiratory function in some severe COVID-19 cases

A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe coronavirus disease 2019 (COVID-19).

14 May 2020

11 healthcare centers participate in clinical trial of Russian drug against novel coronavirus

Initially, the drug was developed to treat rheumatoid arthritis. BIOCAD developers receive regulatory authorization as part of the procedure approved by Decree No. 441 of the Government of the Russian Federation of April 4, 2020 since the mechanism of action of the active substance is associated with the cytokine storm, a life-threatening immune system response in patients with COVID-19.

14 May 2020

Trump’s comparison of COVID-19 death rates in Germany, US is wrong

Following weeks of criticism over his administration's COVID-19 response, President Donald Trump pulled out new statistics to claim the nation is actually among the best in the world in fighting the lethal coronavirus.

14 May 2020

SCAI releases recommendations for managing patients with out-of-hospital cardiac arrest

The Society for Cardiovascular Angiography and Interventions has released an expert consensus statement describing recommendations for the management of patients with out-of-hospital cardiac arrest.

14 May 2020

New research and guidance focus on critical health aspects during COVID-19 epidemic

New research and guidance in the American Journal of Preventive Medicine, published by Elsevier, focus on critical topics pertaining to community and individual health during the COVID-19 epidemic.

14 May 2020

Comparison of flu deaths with COVID-19 deaths

A new study published in the journal JAMA Internal Medicine in May 2020 reports that false comparisons between the count of COVID-19 deaths as reported by various hospitals in the US, and the estimated flu-related deaths, causes significant confusion and may impair the ability to design public health policies.

14 May 2020

Relaxation of social and physical distancing measures may result in profound mortality

Even as the world struggles to live and make a living, faced with the dual threat of a rapidly spreading viral illness and economic slowdown, a new study published on the preprint server medRxiv in May 2020 says that relaxing non-pharmacological interventions will allow the SARS-CoV-2 virus to become endemic.

13 May 2020

Low albumin levels could predict poor outcome in COVID-19

A Spanish study has revealed that COVID-19 patients who have a low level of albumin have a poorer outcome compared to those with normal levels of blood albumin. The study titled, “Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study,” was released prior to peer-review on the open-access preprint server site Medrxiv*.

13 May 2020

COVID-19 lockdown exit strategies: deliverance or disaster?

A new study by researchers at the University of Cambridge, Universidad de Sevilla, and the University of Massachusetts, published on the preprint server medRxiv in May 2020, shows that it is essential to choose a restrictive exit strategy while easing COVID-19 lockdowns, because failure to do so may lead to catastrophic results.

13 May 2020

Does HIV infection increase the severity of COVID-19?

A new study by researchers at the New York University Grossman School of Medicine and published on the preprint server medRxiv* in May 2020 reports that being infected with HIV at the time of acquiring COVID-19 does not significantly increase the severity of illness or the risk of complications.

13 May 2020

C-Path, Provention Bio collaborate to improve scientific community's insight into type 1 diabetes

The Critical Path Institute and Provention Bio, Inc. are proud to announce their collaboration to significantly improve the scientific community's insight into type 1 diabetes through Provention's contribution of data from the Phase III Protégé study of teplizumab to the T1D Trial Outcome Measures Initiative integrated database.

13 May 2020

Should school closures related to COVID-19 be continued long-term?

Since the coronavirus disease 2019 (COVID-19) outbreak was identified in Wuhan, China, in December 2019, many countries have introduced restrictive measures to curb the circulation and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

13 May 2020

UCI Health to initiate clinical trial of a drug to treat critically ill COVID-19 patients

UCI Health will initiate a clinical study of a drug to treat critically ill COVID-19 patients who face a high mortality rate because of acute inflammation that fills their lungs with fluid, a grave condition that even mechanical ventilation cannot improve.

13 May 2020

Researchers urge Ireland government to change recommendations for vitamin D supplements

A new publication from Dr Eamon Laird and Professor Rose Anne Kenny, School of Medicine, and the Irish Longitudinal Study on Ageing (TILDA), in collaboration with Professor Jon Rhodes at University of Liverpool, highlights the association between vitamin D levels and mortality from COVID-19.

13 May 2020

Exposure to fine particulate matter can increase mortality in young patients with certain cancers

An analysis of nearly 16,000 young patients with cancer in Utah revealed that exposure to fine particulate matter was associated with increased mortality at five and 10 years after diagnosis of certain cancers.

13 May 2020

Mortality News and Research

Tissue Solutions and CBSB join forces to increase COVID-19 sample availability

Experts urge health systems to fast-track implementation of Patient Blood Management

SARS-CoV-2 will infect 250 million people in Africa

New insights into SARS-CoV-2 viral diversity

ACTG initiates clinical trial to evaluate treatment for COVID-19

Anti-inflammatory drug may improve respiratory function in some severe COVID-19 cases

11 healthcare centers participate in clinical trial of Russian drug against novel coronavirus

Trump’s comparison of COVID-19 death rates in Germany, US is wrong

SCAI releases recommendations for managing patients with out-of-hospital cardiac arrest

New research and guidance focus on critical health aspects during COVID-19 epidemic

Comparison of flu deaths with COVID-19 deaths

Relaxation of social and physical distancing measures may result in profound mortality

Low albumin levels could predict poor outcome in COVID-19

COVID-19 lockdown exit strategies: deliverance or disaster?

Does HIV infection increase the severity of COVID-19?

C-Path, Provention Bio collaborate to improve scientific community's insight into type 1 diabetes

Should school closures related to COVID-19 be continued long-term?

UCI Health to initiate clinical trial of a drug to treat critically ill COVID-19 patients

Researchers urge Ireland government to change recommendations for vitamin D supplements

Exposure to fine particulate matter can increase mortality in young patients with certain cancers

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News